Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...

The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...

Supporters of the move believe USAID was poorly managed and wasting taxpayers' money, with White House Press Secretary ...

The North Asian private equity giant cited rising demand for semiconductor products amid the AI boom for its decision to ...

Korean Air anticipates uncertainties in the business environment this year due to shifts in the global political landscape, ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it ...

Yu Yi, technology lead at Accenture China, said that as companies strive to stay ahead and adapt to fast-changing markets, ...

Strong private equity investment and strategic M&A in 2024, and a shift toward clinical-stage companies and asset-driven ...

A delay to US tariffs on goods from Mexico and Canada has done little to suggest Trump will change his course on trade levies ...

Beijing may have to eventually stimulate domestic demand aggressively as it did during the previous trade war as China relies ...

Hillenbrand anticipates Q2 revenue in the range of $685 million to $705 million and adjusted EPS between $0.53 and $0.58. Full-year guidance has been updated to reflect the Milacron transaction, ...

Companies across the country are bleeding cash as they struggle with overcapacity and weak spending in a slumping economy, ...